Dogwood Therapeutics (DWTX) Expected to Announce Quarterly Earnings on Wednesday

Dogwood Therapeutics (NASDAQ:DWTX) will likely be announcing its earnings results before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of ($1.36) per share for the quarter.

Dogwood Therapeutics Price Performance

DWTX opened at $5.05 on Tuesday. The stock has a market capitalization of $6.73 million, a P/E ratio of -0.77 and a beta of 1.92. The stock has a 50-day simple moving average of $5.83. Dogwood Therapeutics has a twelve month low of $1.62 and a twelve month high of $29.28.

About Dogwood Therapeutics

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.